Medartis Holding AG
SIX:MED

Watchlist Manager
Medartis Holding AG Logo
Medartis Holding AG
SIX:MED
Watchlist
Price: 86.8 CHF -1.36% Market Closed
Market Cap: CHf1.2B

Wall St Price Targets

MED Price Targets Summary
Medartis Holding AG

Wall Street analysts forecast MED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MED is 106.59 CHF with a low forecast of 105.04 CHF and a high forecast of 110.25 CHF.

Lowest Forecast
Price Target
105.04 CHF
21% Upside
Average Forecast
Price Target
106.59 CHF
23% Upside
Highest Forecast
Price Target
110.25 CHF
27% Upside
Medartis Holding AG Competitors:
Price Targets
AHCO
Adapthealth Corp
44% Upside

Revenue
Forecast

13% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
13% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 7 years is 9%.

Gross Profit
Forecast

12% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
12% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 9 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 18%.

Operating Income
Forecast

15% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
15% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 9 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 7 years is 15%.

Pre-Tax Income
Forecast

10% / Year
Past Growth
57% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
10% / Year
Past Growth
57% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 57%.

Net Income
Forecast

11% / Year
Past Growth
70% / Year
Estimated Growth
Estimates Accuracy
-49%
Average Miss
11% / Year
Past Growth
70% / Year
Estimated Growth
Estimates Accuracy
-49%
Average Miss

Over the last 9 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 70%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MED's stock price target?
Price Target
106.59 CHF

According to Wall Street analysts, the average 1-year price target for MED is 106.59 CHF with a low forecast of 105.04 CHF and a high forecast of 110.25 CHF.

What is the Revenue forecast for Medartis Holding AG?
Projected CAGR
9%

Over the last 9 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 7 years is 9%.

What is the Gross Profit forecast for Medartis Holding AG?
Projected CAGR
18%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 18%.

What is the Operating Income forecast for Medartis Holding AG?
Projected CAGR
15%

Over the last 9 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 7 years is 15%.

What is the Pre-Tax Income forecast for Medartis Holding AG?
Projected CAGR
57%

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 57%.

What is the Net Income forecast for Medartis Holding AG?
Projected CAGR
70%

Over the last 9 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 70%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett